EZH2 and neoplasm: Moreover, in agreement with these results, previous studies reported that the EZH2 loss-of-function mutations and SRSF2Mut occur in the same spectrum of malignant myeloid disorders, where EZH2 seems to behave as a tumor suppressor [122,123,124].